{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T17:09:24Z","timestamp":1724864964660},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T00:00:00Z","timestamp":1526342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00347-018-0719-8","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T11:57:48Z","timestamp":1526385468000},"page":"826-831","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Registerstudien in der Ophthalmologie"],"prefix":"10.1007","volume":"115","author":[{"given":"J.","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. P.","family":"Finger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"key":"719_CR1","volume-title":"Registries for evaluating patient outcomes: a user\u2019s guide","author":"R Glicklich","year":"2007","unstructured":"Glicklich R (2007) Registries for evaluating patient outcomes: a user\u2019s guide"},{"key":"719_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","volume":"369","author":"N Wahlgren","year":"2007","unstructured":"Wahlgren N, Ahmed N, D\u00e1valos A et al (2007) Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369:275\u2013282","journal-title":"Lancet"},{"key":"719_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00103-009-0854-0","volume":"52","author":"B Heinz","year":"2009","unstructured":"Heinz B (2009) Endoprothesenregister und deren Beitrag zur Sicherheit der Patientenversorgung mit Gelenkimplantaten. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 52:589\u2013593","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"719_CR4","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/ard.2007.085852","volume":"68","author":"J Askling","year":"2009","unstructured":"Askling J, Baecklund E, Granath F et al (2009) Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis 68:648\u2013653","journal-title":"Ann Rheum Dis"},{"key":"719_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1001\/jamainternmed.2017.4332","volume":"177","author":"H Wadstrom","year":"2017","unstructured":"Wadstrom H, Frisell T, Askling J (2017) Malignant neoplasms in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, tocilizumab, abatacept, or rituximab in clinical practice: a nationwide cohort study from Sweden. JAMA Intern Med 177:1605\u20131612","journal-title":"JAMA Intern Med"},{"key":"719_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10049-013-1696-8","volume":"16","author":"R Lefering","year":"2013","unstructured":"Lefering R, Nienaber U, Paffrath T (2013) TraumaRegister DGU\u00ae der Deutschen Gesellschaft f\u00fcr UnfallchirurgieTraumaRegister DGU\u00ae of the German Trauma Society. Notfall Rettungsmed 16:269\u2013273","journal-title":"Notfall Rettungsmed."},{"key":"719_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00103-004-0826-3","volume":"47","author":"U Zeymer","year":"2004","unstructured":"Zeymer U, Senges J (2004) Qualit\u00e4tsregister in der Kardiologie. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47:533\u2013539","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"719_CR8","volume-title":"Swedish National Quality Registries","author":"N Kvalitetsregister","year":"2018","unstructured":"Kvalitetsregister N (2018) Swedish National Quality Registries"},{"key":"719_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SA, Sandegaard JL et\u00a0al (2015) The Danish National Patient Registry: a\u00a0review of content, data quality, and research potential. Clin Epidemiol 7:449\u2013490","journal-title":"Clin Epidemiol"},{"key":"719_CR10","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1055\/s-0030-1263132","volume":"72","author":"D M\u00fcller","year":"2010","unstructured":"M\u00fcller D, Augustin M, Banik N et\u00a0al (2010) Memorandum Register f\u00fcr die Versorgungsforschung. Gesundheitswesen 72:824\u2013839","journal-title":"Gesundheitswesen"},{"key":"719_CR11","first-page":"783","volume":"114","author":"JR Windeler","year":"2017","unstructured":"Windeler JR, Lauterberg J, Wieseler B et\u00a0al (2017) Patientenregister f\u00fcr die Nutzenbewertung: Kein Ersatz f\u00fcr randomisierte Studien. Dtsch Arztebl Int 114:783","journal-title":"Dtsch Arztebl Int"},{"key":"719_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00113-016-0176-2","volume":"119","author":"E Neugebauer","year":"2016","unstructured":"Neugebauer E, Stausberg J (2016) Was Register leisten k\u00f6nnen und was nicht. Unfallchirurg 119:493\u2013500","journal-title":"Unfallchirurg"},{"key":"719_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jcrs.2012.10.037","volume":"39","author":"E Friling","year":"2013","unstructured":"Friling E, Lundstrom M, Stenevi U et al (2013) Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J\u00a0Cataract Refract Surg 39:15\u201321","journal-title":"J Cataract Refract Surg"},{"key":"719_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/aos.12490","volume":"93","author":"K Mollazadegan","year":"2015","unstructured":"Mollazadegan K, Lundstrom M (2015) A study of the correlation between patient-reported outcomes and clinical outcomes after cataract surgery in ophthalmic clinics. Acta Ophthalmol (Copenh) 93:293\u2013298","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"719_CR15","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1111\/aos.13069","volume":"94","author":"JM Walz","year":"2016","unstructured":"Walz JM, Bemme S, Pielen A et\u00a0al (2016) The German ROP Registry: data from 90 infants treated for retinopathy of prematurity. Acta Ophthalmol (Copenh) 94:e744\u2013e752","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"719_CR16","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jamaophthalmol.2016.3229","volume":"134","author":"JE Thorne","year":"2016","unstructured":"Thorne JE, Suhler E, Skup M et al (2016) Prevalence of noninfectious uveitis in the United States: a claims-based analysis. Jama Ophthalmol 134:1237\u20131245","journal-title":"Jama Ophthalmol"},{"key":"719_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","volume":"111","author":"DC Gritz","year":"2004","unstructured":"Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 111:491\u2013500","journal-title":"Ophthalmology"},{"key":"719_CR18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1055\/s-2005-858753","volume":"222","author":"A Heiligenhaus","year":"2005","unstructured":"Heiligenhaus A, Niewerth M, Mingels A et\u00a0al (2005) Epidemiology of uveitis in juvenile idiopathic arthritis from a\u00a0national paediatric rheumatologic and ophthalmologic database. Klin Monbl Augenheilkd 222:993\u20131001","journal-title":"Klin Monbl Augenheilkd"},{"key":"719_CR19","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","volume":"46","author":"A Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Niewerth M, Ganser G et al (2007) Prevalence and complications of uveitis in juvenile idiopathic arthritis in a\u00a0population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 46:1015\u20131019","journal-title":"Rheumatology (Oxford)"},{"key":"719_CR20","first-page":"936","volume":"33","author":"C Tappeiner","year":"2015","unstructured":"Tappeiner C, Klotsche J, Schenck S et al (2015) Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis:data from a\u00a0cross-sectional analysis of a\u00a0prospective nationwide study. Clin Exp Rheumatol 33:936\u2013944","journal-title":"Clin Exp Rheumatol"},{"key":"719_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/acr.22649","volume":"68","author":"C Tappeiner","year":"2016","unstructured":"Tappeiner C, Schenck S, Niewerth M et\u00a0al (2016) Impact of antiinflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: longitudinal analysis from a\u00a0nationwide pediatric rheumatology database. Arthritis Care Res 68:46\u201354","journal-title":"Arthritis Care Res"},{"key":"719_CR22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1509852","volume":"375","author":"GJ Jaffe","year":"2016","unstructured":"Jaffe GJ, Dick AD, Br\u00e9zin AP et\u00a0al (2016) Adalimumab in patients with active noninfectious uveitis. N\u00a0Engl J Med 375:932\u2013943","journal-title":"N Engl J Med"},{"key":"719_CR23","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","volume":"388","author":"QD Nguyen","year":"2016","unstructured":"Nguyen QD, Merrill PT, Jaffe GJ et al (2016) Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a\u00a0multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet 388:1183\u20131192","journal-title":"Lancet"},{"key":"719_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","volume":"129","author":"C Lowder","year":"2011","unstructured":"Lowder C, Belfort R Jr., Lightman S et\u00a0al (2011) Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 129:545\u2013553","journal-title":"Arch Ophthalmol"},{"key":"719_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/09286580701585892","volume":"15","author":"JH Kempen","year":"2008","unstructured":"Kempen JH, Daniel E, Gangaputra S et al (2008) Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol 15:47\u201355","journal-title":"Ophthalmic Epidemiol"},{"key":"719_CR26","doi-asserted-by":"publisher","first-page":"b2480","DOI":"10.1136\/bmj.b2480","volume":"339","author":"JH Kempen","year":"2009","unstructured":"Kempen JH, Daniel E, Dunn JP et\u00a0al (2009) Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ 339:b2480","journal-title":"BMJ"},{"key":"719_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","volume":"149","author":"E Daniel","year":"2010","unstructured":"Daniel E, Thorne JE, Newcomb CW et\u00a0al (2010) Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol 149:423\u2013432.e1\u20132","journal-title":"Am J Ophthalmol"},{"key":"719_CR28","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","volume":"116","author":"S Gangaputra","year":"2009","unstructured":"Gangaputra S, Newcomb CW, Liesegang TL et\u00a0al (2009) Methotrexate for ocular inflammatory diseases. Ophthalmology 116:2188\u20132198.e1","journal-title":"Ophthalmology"},{"key":"719_CR29","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2009.08.010","volume":"117","author":"RO Kacmaz","year":"2010","unstructured":"Kacmaz RO, Kempen JH, Newcomb C et\u00a0al (2010) Cyclosporine for ocular inflammatory diseases. Ophthalmology 117:576\u2013584","journal-title":"Ophthalmology"},{"key":"719_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","volume":"148","author":"S Pasadhika","year":"2009","unstructured":"Pasadhika S, Kempen JH, Newcomb CW et\u00a0al (2009) Azathioprine for ocular inflammatory diseases. Am J Ophthalmol 148:500\u2013509.e2","journal-title":"Am J Ophthalmol"},{"key":"719_CR31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","volume":"117","author":"SS Pujari","year":"2010","unstructured":"Pujari SS, Kempen JH, Newcomb CW et\u00a0al (2010) Cyclophosphamide for ocular inflammatory diseases. Ophthalmology 117:356\u2013365","journal-title":"Ophthalmology"},{"key":"719_CR32","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.ophtha.2017.03.041","volume":"124","author":"E Daniel","year":"2017","unstructured":"Daniel E, Pistilli M, Kothari S et\u00a0al (2017) Risk of ocular hypertension in adults with noninfectious uveitis. Ophthalmology 124:1196\u20131208","journal-title":"Ophthalmology"},{"key":"719_CR33","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.ophtha.2015.06.041","volume":"122","author":"S Kothari","year":"2015","unstructured":"Kothari S, Foster CS, Pistilli M et\u00a0al (2015) The risk of Intraocular pressure elevation in pediatric noninfectious uveitis. Ophthalmology 122:1987\u20132001","journal-title":"Ophthalmology"},{"key":"719_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bjo.80.4.332","volume":"80","author":"A Rothova","year":"1996","unstructured":"Rothova A, Suttorp-Van Schulten M, Treffers WF et al (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80:332\u2013336","journal-title":"Br J Ophthalmol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-018-0719-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-018-0719-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-018-0719-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T20:10:11Z","timestamp":1557864611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-018-0719-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1007\/s00347-018-0719-8","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]},"assertion":[{"value":"15 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Li, C.\u00a0Heinz und R.\u00a0P.\u00a0Finger geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}